MS-N179 · Mind–body and psychosexual support · Appraised October 30, 2026

Sexual mindfulness for sexual well-being after breast cancer

Aliases: Sexual mindfulness-based training

Evidence at a glance

Question: Can an eight-session sexual-mindfulness program improve sexual well-being in women treated for breast cancer?
Finding: A small Iranian randomized trial found no significant between-group difference immediately after training, but reported higher sexual-well-being scores at three months. Attrition, convenience sampling and lack of an attention control make the result preliminary.
Evidence label: Preliminary randomized signal
Benefit: Possible delayed improvement in a self-reported supportive-care outcome.
Certainty: Low. Thirty-two women were randomized and 24 completed follow-up; the analysis was not a robust intention-to-treat assessment.
Risk: No intervention harm was identified in the report, but adverse-event collection was not described.
Cancer-control boundary: This study did not measure tumor response, recurrence or survival.

Study details

Intervention: Eight weekly 90-minute sexual-mindfulness sessions; the research regimen is not a personal treatment prescription.
Population and setting: Women with breast cancer recruited through comprehensive health centers in Shahrekord, Iran; participants were sexually active, married and living with a spouse.
Design and comparator: Randomized clinical trial; training versus no planned intervention or training.
Sample: Thirty-six selected; four excluded for severe depression; 32 randomized, 16 per group; 12 per group remained at follow-up.
Outcome and follow-up: Self-reported sexual well-being immediately after the program and at three months.
Results: Immediate between-group comparison was not significant (P=.11). At three months, mean scores were 66.42 in the intervention group and 51.92 in control (P<.001).
Negative findings: The immediate between-group result was null.
Limitations: Convenience sample, 25% post-randomization attrition, no attention control, narrow eligibility and self-reported outcome. Clinical importance of the score difference was not established.
Funding and conflicts: Funded by Shahrekord University of Medical Sciences, grant 4380. Authors declared no conflicts.

Practical safety context

Sexual concerns can involve pain, vaginal dryness, treatment-related menopause, trauma, relationship strain or depression. A mindfulness course should not delay assessment for treatable symptoms, safeguarding concerns or severe psychological distress.

Questions for the care team

Would evaluation for pain, dryness, medication effects or depression be more useful first?
Is the facilitator trained in cancer-related sexual health and trauma-informed care?
What outcome would count as meaningful improvement for me?

Primary sources

Last literature search: October 30, 2026 · Record appraisal: October 30, 2026

Educational evidence summary, not medical advice. Do not change cancer treatment or supportive medications without discussing the decision with the treating team.